Additional information
| Weight | 5 kg |
|---|---|
| Dimensions | 10 cm |
₹1,200.00 Original price was: ₹1,200.00.₹1,150.00Current price is: ₹1,150.00.
| Weight | 5 kg |
|---|---|
| Dimensions | 10 cm |
Elevated CA 125 levels are seen in many patients with cancer of the ovary. The percentage of positive cases increases with stage of the cancer. This assay is useful for evaluating patient’s response to ovarian cancer therapy. It also helps in predicting recurrent ovarian cancer or intraperitoneal tumor.
This assay is useful for predicting early recurrence in women treated for Carcinoma Breast. It is specially useful for serial testing in women with prior Stage II / III breast cancer who are clinically free of disease
Increased levels of CEA are found in patients with primary Colorectal carcinoma and other malignancies like Medullary thyroid carcinoma and Carcinoma of breast, GI tract, liver, lung, ovarian, pancreatic and prostate. Serial monitoring of CEA should begin prior to therapy to establish a baseline for evaluating possible recurrence. Levels generally return to normal within 1 to 4 months after removal of tumor. Smokers show a higher baseline level of CEA
A female cancer profile test, also known as a cancer detection profile, is a series of blood tests that measure tumor markers, which are substances that can be elevated in the blood of some people with certain types of cancers, particularly those affecting females.
The tests are designed to detect and monitor cancers that are more common in women, such as breast, ovarian, and cervical cancer.
Measures CA 19.9, which an antibody released in cases of certain cancer, especially pancreatic cancer.
These tests are not a definitive diagnosis, and further tests may be needed to confirm a cancer diagnosis.
It’s important to discuss the results of these tests with a doctor to determine the next steps.
Some of these tests are used for screening (to detect cancer early), while others are used for diagnosis or monitoring treatment.
In addition to blood tests, other screening tests, such as mammograms, Pap tests, and colonoscopies, are also important for detecting cancer in women.